REGU09008 2019 US Medical Technology Regulatory Affairs Advanced
Full Title
US Medical Technology Regulatory Affairs Advanced
Transcript Title
US Medical Technology Regulato
Code
REGU09008
Attendance
N/A %
Subject Area
REGU - Regulatory Affairs
Department
LIFE - Life Sciences
Level
09 - NFQ Level 9
Credit
05 - 05 Credits
Duration
Semester
Fee
€
Start Term
2019 - Full Academic Year 2019-20
End Term
9999 - The End of Time
Author(s)
Mary Butler
Programme Membership
SG_SMEDI_O09 201900 Postgraduate Diploma in Science in Medical Device Regulatory Affairs
SG_SMEDI_M09 201900 Master of Science in Medical Technology Regulatory Affairs
SG_SMEDI_C09 202100 Postgraduate Certificate in Medical Device Regulatory Affairs
Description
This module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the regulatory pathway for placing medical devices on the market in the US, US Law (FD&C Act) and regulations, the code of federal regulations (CFR), submission types, change control, post market requirements and emerging technologies.
Learning Outcomes
On completion of this module the learner will/should be able to;
1.
Demonstrate they have detailed knowledge and understanding of the submission types involved by demonstrating a strategic knowledge of the structure and technical contents of the many different submission types from simple registrations through to 510(k)s, PMAs, IDEs, De Novos etc. and appropriate supplements such as a 30-day supplement or an annual report through a series of appropriate essays, assignments and literature review.
2.
Formulate and communicate judgements with regard to best practices and strategic regulatory decision making process for devices and demonstrate ability to interact effectively with FDA agents through systems such as a 513(g) or pre-submission process.
3.
Analyse and evaluate data from US FDA MAUDE (Manufacturer and user facility device experience) database.
4.
Communicate a detailed knowledge and understanding of how to manage change control for a product destined for US market.
5.
Source and interpret relevant reimbursement requirements.
6.
Develop strategies to navigate the US regulations efficiently in the context of an international market.
Teaching and Learning Strategies
The educational elements will be provided by the Institute of Technology Sligo and NUI Galway staff. Additional lecturing, as required, may be provided by outside specialists and practitioners. Online/blended programmes are designed for students who want to study part-time at a pace that matches their work-life balance. Through a combination of blended delivery formats including online (synchronous and asynchronous) as well as other technologies we strive to reach the forefront of emerging breakthroughs in the delivery and assessment of online students.
Module Assessment Strategies
The module will be assessed on the basis of 100% continuous assessment. Some or all of the following assessment modes may apply: examinations, practical work, projects, essays, vivas, seminars, and assignments. These assessments may be organised at different centres throughout the country and a selection of assignments may be assessed.
Sample Technologies in use during assessments
• Moodle
• Adobe connect
• Turnitin
• Panopto
• Microsoft office
• Multimedia including DVDs, webinars, youtube video clips, online videos
Repeat Assessments
The programme allows students to progress to a next stage if they have failed to attain the pass mark for a particular module. A student may be allowed to carry up to 10 credits into a new stage. This policy is at the discretion of the examination board.
Indicative Syllabus
The following is a summary of the main topics included in this particular module: US FDA structure and function, administrative and legislative structure of the FD&C Act, regulatory pathways; classification; Consensus standards; Quality System Regulation (21 CFR 820); Post market surveillance requirements; navigating the FDA databases and Code of federal Regulations (CFR)emerging technologies.
Coursework & Assessment Breakdown
Coursework & Continuous Assessment
100 %
Coursework Assessment
| Title | Type | Form | Percent | Week | Learning Outcomes Assessed | |
|---|---|---|---|---|---|---|
| 1 | Assignment written assignment | Coursework Assessment | Assignment | 55 % | Week 12 | 1,2,3,4,5,6 |
| 2 | Case Study essay and dummy submission compilation (formative) | Coursework Assessment | Assessment | 20 % | Week 8 | 1,2,4,6 |
| 3 | e-activity Literature analysis | Coursework Assessment | Assignment | 15 % | Week 10 | 1,2,6 |
| 4 | Communication Activity | Coursework Assessment | Assessment | 10 % | Week 11 | 2 |
Part Time Mode Workload
| Type | Location | Description | Hours | Frequency | Avg Workload |
|---|---|---|---|---|---|
| Online Lecture | Not Specified | Lecture | 2 | Weekly | 2.00 |
Total Part Time Average Weekly Learner Contact Time 2.00 Hours
Required & Recommended Book List
Recommended Reading
2011-04-07 Medical Device Design and Regulation Quality Press
ISBN 0873898168 ISBN-13 9780873898164
2011-04-07 Medical Device Design and Regulation Quality Press
ISBN 0873898168 ISBN-13 9780873898164
The intent of this book (MDDR, for short) is to present an introduction to, and overview of, the world of medical device regulation by the United States Food and Drug Administration (FDA), and the relationship of this regulatory scheme to the design and development of medical devices. In providing this information, the book covers the broad range of requirements, which are presented within eight major topics: background and regulatory environment, device design control, nonclinical testing, clinical testing, marketing applications, post-market requirements, quality systems/GMPs, and compliance/enforcement. This book provides students and professionals in the medical device industry with a road map to the regulation of medical devices. It provides a broad understanding of the breadth and depth of medical device regulation by collecting in one textbook coverage of the regulatory scheme for medical devices in terms that are suitable for engineers, scientists, and healthcare providers. The vast amount of information available on the subject is distilled into a concise and coherent presentation. There also are problems and projects at the end of each chapter. In addition to the usual questions requiring specific answers, the projects include the drafting of a device control plan, the development of a nonclinical test procedure, the resolution of a recall, the response to a Warning Letter, and the creation of a CAPA for a device deficiency. A solutions manual for these exercises is available to teachers who adopt the textbook for classroom use. Medical Device Design and Regulation (MDDR) also makes available over 100 complimentary live hyperlinks to web pages with additional relevant information, and offers users the opportunity to join and participate in the MDDR Users Group on LinkedIn.
Recommended Reading
2014-01-23 FDA Regulatory Affairs: Third Edition CRC Press
2014-01-23 FDA Regulatory Affairs: Third Edition CRC Press
FDA Regulatory Affairs is a roadmap to prescription drug, biologics, and medical device development in the United States. Written in plain English, the concise and jargon-free text demystifies the inner workings of the US Food and Drug Administration (FDA) and facilitates an understanding of how the agency operates with respect to compliance and product approval, including clinical trial exemptions, fast track status, advisory committee procedures, and more.
The Third Edition of this highly successful publication:
- Examines the harmonization of the US Federal Food, Drug, and Cosmetic Act with international regulations on human drug, biologics and device development, research, manufacturing, and marketing
- Includes contributions from experts at organizations such as the FDA, National Institutes of Health (NIH), and PAREXEL
- Focuses on the new drug application (NDA) process, cGMPs, GCPs, quality system compliance, and corresponding documentation requirements
- Provides updates to the FDA Safety and Innovation Act (FDASIA), incorporating pediatric guidelines and follow-on biologics regulations from the 2012 Prescription Drug User Fee Act (PDUFA) V
- Explains current FDA inspection processes, enforcement options, and how to handle FDA meetings and required submissions
Co-edited by an industry leader (Mantus) and a respected academic (Pisano), FDA Regulatory Affairs, Third Edition delivers a compilation of the selected US laws and regulations as well as a straightforward commentary on the FDA product approval process thats broadly useful to both business and academia.
Module Resources
Non ISBN Literary Resources
|
Carl T. DeMarco 2011 Medical Device Design and Regulation Quality Press ISBN-10 0873898168 ISBN-13 9780873898164 |
|
2014 FDA Regulatory Affairs: Third Edition CRC Press ISBN-10 ISBN-13 |
Journal Resources
|
Carl T. DeMarco 2011 Medical Device Design and Regulation Quality Press ISBN-10 0873898168 ISBN-13 9780873898164 |
|
2014 FDA Regulatory Affairs: Third Edition CRC Press ISBN-10 ISBN-13 |
URL Resources
http://www.fda.gov/
General web references include:
FDA - Device Advice:
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/default.htm
FDA Databases - useful for research :
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Databases/defa
ult.htm
Appropriate Webinars, whilte papers and blogs.
RAPS magazine
Other Resources
None
Additional Information
None